Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Cerebral Hemorrhage; Hemorrhage; Pneumonia Phase 2/Phase 3 ClinicalTrials
Pneumonia; Stroke Phase 2 ClinicalTrials
CONTENTS